| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006953039 |
| P356 | DOI | 10.1097/GIM.0B013E3181770184 |
| P932 | PMC publication ID | 2764316 |
| P698 | PubMed publication ID | 18496223 |
| P50 | author | Wylie Burke | Q46002111 |
| P2093 | author name string | Alexandra E Shields | |
| Douglas E Levy | |||
| P2860 | cites work | Access to orthopedic care for children with medicaid versus private insurance in California | Q46350027 |
| Does the content of primary care visits differ by the racial composition of physicians' practices? | Q46449900 | ||
| Evidence suggesting the role of specific genetic factors in cigarette smoking | Q46577802 | ||
| Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer | Q46701366 | ||
| Ethnic differences in risk perception among women at increased risk for breast cancer | Q46978126 | ||
| US physicians' attitudes toward genetic testing for cancer susceptibility. | Q54433532 | ||
| International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease | Q72819471 | ||
| Clinical application of pharmacogenetics | Q73812542 | ||
| Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk | Q73840671 | ||
| Unequal treatment: confronting racial and ethnic disparities in health care | Q74555036 | ||
| Genetics moves into the medical mainstream | Q77180026 | ||
| The duration of ambulatory visits to physicians | Q77403010 | ||
| Sources of health insurance and characteristics of the uninsured: analysis of the March 2006 current population survey | Q79298998 | ||
| ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent | Q80413269 | ||
| Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer | Q81644523 | ||
| Confronting genetic testing disparities: knowledge is power | Q81644544 | ||
| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
| Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus | Q28771769 | ||
| Reconsidering the family history in primary care | Q30910857 | ||
| Pharmacogenetics and the practice of medicine | Q33906823 | ||
| The global burden of chronic diseases: overcoming impediments to prevention and control | Q34323994 | ||
| Primary care physicians who treat blacks and whites | Q34338807 | ||
| Genetics education for primary-care providers | Q34718177 | ||
| Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians | Q34722733 | ||
| Breast cancer genetics in African Americans | Q35030244 | ||
| Elucidating the role of genetic factors in smoking behavior and nicotine dependence | Q35081791 | ||
| Huntington disease in Maryland: clinical aspects of racial variation | Q35199222 | ||
| The association between race and attitudes about predictive genetic testing. | Q35684925 | ||
| Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. | Q36075259 | ||
| Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement | Q36250211 | ||
| Disparities in genetic testing: thinking outside the BRCA box. | Q36472213 | ||
| Racial disparities in the quality of care for enrollees in medicare managed care | Q38490240 | ||
| Variations in the use of medication for the treatment of childhood asthma in the Michigan Medicaid population, 1980 to 1986. | Q39404617 | ||
| Patterns of ordering diagnostic tests for patients with acute low back pain. The North Carolina Back Pain Project | Q39436221 | ||
| Hypertension, obesity and GNB 3 gene variants | Q39746163 | ||
| Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease | Q40630247 | ||
| Primary care physicians as providers of frontline genetic services | Q41082931 | ||
| Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality | Q41729158 | ||
| Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. | Q42483973 | ||
| Measuring and predicting surgeons' practice styles for breast cancer treatment in older women | Q42644632 | ||
| Huntington's disease in black kindreds in South Carolina | Q45306550 | ||
| Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey | Q46187495 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | United States of America | Q30 |
| P304 | page(s) | 404-414 | |
| P577 | publication date | 2008-06-01 | |
| P1433 | published in | Genetics in Medicine | Q15765508 |
| P1476 | title | Differential use of available genetic tests among primary care physicians in the United States: results of a national survey | |
| P478 | volume | 10 |
| Q58578462 | African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study |
| Q37237966 | Age at diagnosis may trump family history in driving BRCA testing in a population of breast cancer patients |
| Q91989395 | An Applied Framework in Support of Shared Decision Making about BRCA Genetic Testing |
| Q47101552 | Application of active learning modalities to achieve medical genetics competencies and their learning outcome assessments |
| Q33783281 | Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy |
| Q87910367 | Association of Racial/Ethnic Categories With the Ability of Genetic Tests to Detect a Cause of Cardiomyopathy |
| Q36208056 | Attitudes and practices among internists concerning genetic testing |
| Q34311421 | Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity |
| Q37639406 | BRCA sequencing and large rearrangement testing in young Black women with breast cancer |
| Q46193893 | Barriers to the use of genetic testing: a study of racial and ethnic disparities |
| Q35549090 | Breast cancer genetic counselling referrals: how comparable are the findings between the UK and the Netherlands? |
| Q34112137 | Cancer genetic risk assessment and referral patterns in primary care |
| Q40445128 | Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing |
| Q35263766 | Challenges in recruiting Mexican women for cancer genetics research. |
| Q34458626 | Challenges in the care for consanguineous couples: an exploratory interview study among general practitioners and midwives |
| Q33541739 | Cholesterol treatment with statins: who is left out and who makes it to goal? |
| Q64288335 | Clinical genetic testing in medical education |
| Q92667773 | Delivering genomic medicine in the United Kingdom National Health Service: a systematic review and narrative synthesis |
| Q47210509 | Development and evaluation of a genomics training program for community health workers in Texas |
| Q34691719 | Differences in BRCA counseling and testing practices based on ordering provider type |
| Q58616301 | Disparities in genetic services utilization in a random sample of young breast cancer survivors |
| Q64088031 | Driving the precision medicine highway: community health workers and patient navigators |
| Q35286480 | Ethical concerns related to developing pharmacogenomic treatment strategies for addiction. |
| Q52672621 | Evaluating and improving the implementation of a community-based hereditary cancer screening program. |
| Q64137367 | Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework |
| Q35854671 | Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer |
| Q33764057 | Family history of cancer associated with breast tumor clinicopathological features |
| Q36061256 | Genetic testing behavior and reporting patterns in electronic medical records for physicians trained in a primary care specialty or subspecialty |
| Q35113219 | Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. |
| Q34157264 | Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice |
| Q37234825 | Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer |
| Q36935684 | Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians |
| Q38681805 | Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment |
| Q38119343 | Knowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancer. |
| Q36717823 | Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer |
| Q50033931 | Observed frequency and challenges of variant reclassification in a hereditary cancer clinic. |
| Q36041690 | Perceptions about genetic testing for the susceptibility to alcohol dependence and other multifactorial diseases |
| Q36673624 | Pharmacogenetics in primary care: the promise of personalized medicine and the reality of racial profiling |
| Q88551185 | Physician interpretation of variants of uncertain significance |
| Q37712065 | Physicians' attitudes about multiplex tumor genomic testing |
| Q36481170 | Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families |
| Q36229139 | Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda |
| Q42364504 | Racial minority group interest in direct-to-consumer genetic testing: findings from the PGen study |
| Q36997258 | Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testing |
| Q45847055 | Reacting to genetic risk: an experimental survey of life between health and disease |
| Q93134145 | Regional models of genetic services in the United States |
| Q39992636 | Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study |
| Q53440051 | Review and Comparison of Electronic Patient-Facing Family Health History Tools. |
| Q53085241 | Risk for Patient Harm in Canadian Genetic Counseling Practice: It's Time to Consider Regulation. |
| Q58786293 | Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care |
| Q34328987 | Technical report: Ethical and policy issues in genetic testing and screening of children |
| Q35989670 | The influence of health care policies and health care system distrust on willingness to undergo genetic testing |
| Q38967942 | The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes |
| Q36706640 | Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk |
| Q37401308 | Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities |
| Q63213733 | Utilization Management of Genetic Testing |
| Q36589069 | Views of internists towards uses of PGD |
Search more.